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Background: T cells and B cells communicate by direct
cell-cell interaction that is crucial to the functioning of the
immune system. It is well established that the interaction
between B-cell-expressed CD40 and T-cell-expressed
CD40 ligand (CD40L) is critical for T-cell-dependent
antibody responses, but the role of this interaction in
T-cell responses is less clear. In this study, we have used
mice with targeted mutations in the genes encoding
CD40L or CD28 to investigate how the CD40-CD40L
interaction induces on B cells a costimulatory activity that
acts in addition to antigen to trigger T-cell growth.
Results: We show that T cells from CD40L-deficient
mice induce a substantially reduced costimulatory activity
on B cells compared to wild-type T cells, particularly at
early time points. Surprisingly, T cells from CD40L-
deficient mice induce similar levels of B7-1 and B7-2 as
do wild-type T cells. We further show that the CD40L-
mediated induction of costimulatory activity precedes the
induction of B7-1, B7-2 and the heat-stable antigen
(HSA). CD4 T cells isolated from the CD28-deficient
mice can receive costimulatory activity from CD40L-
induced B cells, demonstrating that the induced mol-
ecules can costimulate T cells by a CD28-independent
mechanism. We have generated a novel monoclonal anti-
body that inhibits the CD40L-induced costimulatory
activity. Expression of the epitope detected by this mono-
clonal antibody correlates with the induction of the
costimulatory activity, and the molecule recognized by
the monoclonal antibody is a single chain of around
85 kDa, distinct from B7-1, B7-2, ICAM-1, ICAM-2,
ICAM-3, HSA, CD5, integrin and 4-1BB ligand.
Conclusions: Our results demonstrate that CD40L is
both necessary and sufficient for rapid, T-cell-mediated
induction of costimulatory activity on B cells. This
costimulatory activity is distinct from B7-1 and B7-2, and
is independent of CD28.
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Background
The interaction between T cells and B cells is the proto-
typical example of cell-cell interaction in the immune sys-
tem. The basis for the specificity of this interaction was
established 10 years ago by the elegant study of Lanzavec-
chia [1], which showed that the interaction of antigen with
the B-cell surface immunoglobulin allows specific antigen
uptake, processing and presentation - to T cells - of an
antigenic peptide in association with class II major histo-
compatibility complex (MHC) molecules. It was assumed
that the T cells that recognize the MHC-bound antigen
would then be activated and deliver the 'help' to B cells
that is required for a robust antibody response [2].
Recent studies have shown, however, that T-cell activa-
tion requires two types of biological signal: one delivered
by engagement of the T-cell receptor (TCR), which
determines the specificity of T-cell activation, and the
other delivered by a 'costimulatory' pathway, which
determines the fate of T cells [3-11]. Several costimula-
tory molecules, such as B7-1, B7-2 and the heat-stable
antigen (HSA), have been shown to be involved in pro-
moting T-cell clonal expansion and preventing T-cell
inactivation following TCR engagement [12-15]. These
three costimulatory molecules are expressed either
constitutively or inducibly on B cells [12-19]. Because of
the active role of B cells in T-cell responses, we and oth-
ers have proposed that immunological help is delivered
reciprocally between T and B cells [19-22].
The interaction between B cells and T cells mediated by
B-cell-expressed CD40 and T-cell-expressed CD40 lig-
and (CD40L) is necessary for T cells to deliver help to
cognate B cells. Several groups have shown that mutations
in the gene encoding CD40L are responsible for the X-
linked hyper-immunoglobulin M (IgM) syndrome in
human patients [23-26]. In mice, it has been demon-
strated that the CD40-CD40L interaction can be blocked
by an anti-CD40L monoclonal antibody [27], or by solu-
ble CD40L fusion protein [28]; more recently, mice with
a targeted mutation of the CD40L gene have been gen-
erated [29]. Disruption of the CD40-CD40L interaction
in these ways leads to a profound deficiency in the for-
mation of germinal centers, the generation of memory
antibody responses, and antibody class switching.
Three pieces of evidence strongly suggest that this pathway
is also responsible for induction of the costimulatory activ-
ity required for T-cell growth. Firstly, an antibody directed
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against CD40L has been shown to inhibit the activation of
transgenic T cells [22]. Secondly, antibodies directed against
CD40L [22] or CD40 [30] inhibit the induction by T cells
of B7-1 and B7-2, two important costimulatory molecules
for T-cell activation. Thirdly, recombinant CD40L has
been shown to induce a CTLA4 ligand on B cells - most
likely B7-1 or B7-2 [19]. These findings indicate that the
CD40-CD40L interaction switches on costimulatory
activity on B cells by inducing expression of B7. However,
the inhibition of the T-cell response by an antibody could
be due to a negative signaling mechanism. More impor-
tantly, these three studies evaluated the induced costimula-
tory molecules after 24-48 hours of CD40L-CD40
engagement. As the consequences of TCR engagement are
determined within 6 hours [31,32], the physiological sig-
nificance of such costimulatory activity induced after
24 hours of CD40L-CD40 interaction is questionable.
We have recently generated mice with a targeted muta-
tion in the gene encoding CD40L [29]. In order to avoid
the two major caveats mentioned above, we have used
these mice to examine the importance and nature of the
costimulatory activity that is induced by the CD40L-
CD40 interaction. Our results demonstrate that CD40L
rapidly induces a novel costimulatory activity that is dis-
tinct from B7-1, B7-2 and HSA, and that is independent
of CD28.
Results
CD40L is essential for the optimal induction of costimulatory
activity on antigen-presenting cells
Our recent studies have indicated that, in the presence of
anti-CD3 antibody, CD4 T cells induce the expression of
costimulatory activity on syngeneic antigen-presenting
cells (APCs) [16,33]. Using gene-targeted B-cell-
deficient mice, we showed that, in this model, all of the
costimulatory activity induced by T cells is expressed on
B cells [34]. In order to analyze whether the
CD40-CD40L interaction is required for this induction
of costimulatory activity, we used the immune cells of
gene-targeted CD40L-deficient mice. Briefly, spleen cells
were stimulated for a given period and then depleted ofT
cells. The viable APCs were fixed with paraformaldehyde
and their fixation-resistant costimulatory activity deter-
mined by measuring the proliferation of purified CD4 T
cells in response to an anti-CD3 antibody. Fixation of the
APCs prevents further induction of costimulatory activity
by the T cells.
Upon stimulation with the anti-CD3 antibody, signifi-
cant costimulatory activity was induced on T-depleted
spleen cells from wild-type littermates (Fig. la). How-
ever, a six- to nine-fold reduction in costimulatory activ-
ity was observed when the spleen cells from
CD40L-deficient mice were used (Fig. la). The optimal
induction of costimulatory activity also required cell-cell
contact, as T-depleted spleen cells placed in a chamber
and separated from anti-CD3-stimulated spleen cells by a
0.2 .Lm membrane at the induction phase had a much
lower level of costimulatory activity (Fig. lb).
In order to test whether the reduced induction of
costimulatory activity was due to a defect in the T cells,
CD4 T cells from either wild-type or CD40L-deficient
mice were mixed with T-depleted spleen cells from
either strain of mice in the induction phase. The mixture
was then depleted of T cells and the costimulatory activ-
ity on the APCs was determined. As shown in Figure c,
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activity by anti-CD3-activated T cells.
(a) Optimal T-cell-mediated induction
of costimulatory activity requires
CD40L. Spleen cells (5 x 106 m-1) from
either wild-type (WT) or CD40L-defi-
cient (KO) mice were stimulated with an
anti-CD3 antibody for 16 h. T cells were
depleted with an anti-Thyl antibody
plus complement and viable APCs were
fixed with 0.1 % paraformaldehyde, and
used as accessory cells for CD4 T-cell
proliferation in response to an anti-CD3
mAb. (b) Contact is required between T
cells and APCs for T-cell-mediated
induction of costimulatory activity. Total
spleen cells from either wild-type or
CD40L-deficient mice were placed in
the upper chamber of the transwell tis-
sue culture plates, T-depleted cells were
Number of APCs per well ( placed in the lower chamber of theplates and the two chambers were sepa-
rated by a 0.22 pm polycarbonate mem-
brane. The cells were stimulated with an
anti-CD3 mAb for 16 h, and viable T-depleted cells were fixed and used as accessory cells in a CD4 T-cell proliferation assay, as above.(c) The reduced induction of costimulatory activity in CD40L-deficient mice is due to a defect in the T cells. T cells and T-depleted
spleen cells were isolated from either wild-type or CD40L-deficient mice and stimulated with anti-CD3 in the combinations indicated.
After 16 h of stimulation, the viable T-depleted cells were fixed and used as accessory cells in a CD4 T-cell proliferation assay.
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regardless of the source of T-depleted spleen cells, T cells
from wild-type mice could induce costimulatory activity,
whereas T cells from CD40L-deficient mice induced
only low levels of activity. These results indicate that the
defects caused by targeted mutation of the CD40L gene
are due to malfunction of the T cells.
CD40L is not required for T-cell-mediated induction of B7-2
We have shown previously that CD4 T cells induce B7-2
expression on B cells [33]; we therefore tested whether
the differential induction of costimulatory activity by T
cells from wild-type and CD40L-deficient mice was due
to the differential induction of B7-2. Surprisingly, a
comparable level of B7-2 was induced by either source of
T cells (Fig. 2a-d). Similar levels of B7-2 were induced
when the T-depleted spleen cells were separated from T
cells; thus, the induction of B7-2 is contact-independent.
B7-2 expressed on APCs, induced by T cells from wild-
type or CD40L-deficient mice, was immunoprecipitated
with the anti-B7-2 monoclonal antibody GL-1; both
immunoprecipitates showed a similar molecular weight
(Fig. 2e). It is therefore unlikely that the glycosylation of
B7-2 is affected by the CD40L on T cells.
We also compared the kinetics of induction of costimula-
tory activity with that of B7-2 in both wild-type and
CD40L-deficient mice. As shown in Figure 3, the kinet-
ics of B7-2 induction were similar whether wild-type or
CD40L-deficient spleen cells were used. As we have
shown with other strains of mice, HSA was constitutively
expressed and B7-1 was undetectable during the period
studied. However, the induction of costimulatory activity
was significantly slower in the CD40L-deficient spleen
cells. Furthermore, the optimal costimulatory activity
induced by CD40L-deficient T cells was about ten-fold
less than that induced by wild-type T cells.
CD40L-mediated induction of costimulatory activity on
APCs precedes the induction of B7-1/B7-2
A logical, although perhaps unexpected, conclusion from
the above results is that the costimulatory molecules that
are rapidly induced by CD40L are distinct from B7-1,
B7-2 and HSA. In order to test this hypothesis directly,
we used COS cells that were transfected with the CD40L
gene to induce costimulatory activity on T-depleted
Fig. 2. Induction of B7-2 is independent of the expression of
CD40L and of contact between T and B cells. (a-d) The amount of
cell-surface B7-2 as measured by flow cytometry. (a,b) B7-2
expression on T-depleted spleen cells from either CD40L-deficient
mice (dotted lines) or wild-type littermate (solid lines) after total
spleen cells were cultured for 16 h with either (a) medium alone
or (b) medium plus anti-CD3 mAb. (c,d) Expression of B7-2 on
spleen APCs from (c) wild-type or (d) CD40L-deficient mice which
were in contact with (dotted lines), or separated from (solid lines),
T cells during the stimulation in vitro with anti-CD3 mAb. (e) B7-2
molecules isolated from APCs from CD40L-deficient mice and
their wild-type littermates have similar molecular weight distribu-
tions. Spleen cells from (lanes 1,2) wild-type and (lanes 3,4)
CD40L-deficient mice were stimulated for 16 h with anti-CD3
mAb. The T cells were depleted, the remaining viable cells were
cell-surface labeled with 1251 and the specific proteins were
immunoprecipitated with either (lanes 1,3) the control anti-Thy-i
mAb Y19 or (lanes 2,4) anti-B7-2 mAb GL1, as described [451.
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Fig. 3. Kinetics of induction of (a) costimulatory activity and of
(b) the costimulatory molecules B7-2, B7-1 and HSA, in wild-
type and CD40L-deficient mice. Spleen cells from CD40L-defi-
cient and wild-type mice were stimulated for different times, T
cells were then depleted, and the costimulatory activity deter-
mined as described in the legend to Figure 1. The expression of
the costimulatory molecules was determined by flow cytometry
using anti-B7-2 mAb GL-1, anti-HSA mAb M1/69, anti-B7-1
mAbs (a mixture of 1D5, 3A12, and 7A5). The data shown are
mean fluorescence, with background fluorescence (second-step
reagents only) subtracted. The expression of B7-1 in both
CD40L-deficient and wild-type spleen cells was not detectable at
any of the time points tested (< 0), and an artificial number was
used throughout.
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spleen cells, using mock-transfected cells as a control. We
then compared the kinetics of the induced expression of
costimulatory activity with those of the three known
costimulatory molecules, B7-1, B7-2 and HSA. As
shown in Figure 4a, costimulatory activity was induced as
early as within 3 hours of co-culture of T-depleted spleen
cells with the CD40L-transfected COS cells. The costim-
ulatory activity increased and peaked after 24 hours of
co-culture. No significant costimulatory activity was
induced by the mock-transfected COS cells. The anti-
CD40L monoclonal antibody MR1 completely blocked
this induction of costimulatory activity (data not shown).
There was no correlation between the induction of the
costimulatory activity and that of the three costimulatory
molecules studied previously (Fig. 4b). B7-2 was
expressed at equal levels on APCs cultured with either
mock-transfected or CD40L-transfected COS cells at
3 hours and 6 hours of co-culture. At 12 hours, an
increased expression of B7-2 was detected on APCs that
were cultured with CD40L-transfected COS cells. The
level of B7-2 increased steadily on APCs co-cultured
with CD40L-transfected COS cells, but remained con-
stant on APCs co-cultured with mock-transfected COS
cells. The expression of B7-1 was either not observed, or
was at a very low level starting at 24 hours of co-culture
(data not shown). A decrease in the levels of HSA was
observed, although a significant amount of the HSA was
always expressed on the majority of the T-depleted
spleen cells. The lack of correlation between the induc-
tion of B7-2 and the costimulatory activity was not due
to the sensitivity of our fluorescence-activated cell sorter
(FACS) analysis, as a low but significant expression of
B7-2 could be detected on uncultured APCs and on
APCs co-cultured with the mock-transfected COS cells,
which had no detectable costimulatory activity.
CD40L-induced activity costimulates proliferation of T cells
from CD28-deficient mice
In order to test whether the costilmulatory activity that
was distinct from B7-1, B7-2 and HSA depended for its
action on the expression by T cells of CD28, we tested
whether T cells from mice with a targeted mutation in
the CD28 gene could respond to CD40L-induced B
cells. As shown in Figure 5, CD40L-stimulated B cells
had potent costimulatory activity for CD28-deficient T
cells. In contrast, control B cells failed to costimulate
such T cells. At least part of the costimulatory activity
induced by CD40L is therefore independent of CD28.
The response of CD28-deficient T cells was not as
potent as that of wild-type T cells, probably because
wild-type T cells can receive signals from both B7-2 and
the rapidly induced costimulatory molecules - CD28-
deficient resting T cells cannot respond to B7-1 or B7-2
([35] and our unpublished observations).
Characterization of a monoclonal antibody which inhibits
CD40L-induced costimulatory activity
As a first step towards identifying the novel costimulatory
molecule(s) induced on B cells by CD40L, we immu-
nized hamsters with CD40L-stimulated B cells, gener-
ated mouse-hamster hybridomas and screened for
monoclonal antibodies that could bind the costimulatory
molecule(s). Out of 2 400 hybridomas generated, we
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Fig. 4. (a) The kinetics of CD40L-
induced costimulatory activity. T-
depleted spleen cells were co-cultured
with either CD40L- or mock-transfected
COS cells for a given period of time, the
APCs were then fixed and used as
costimulatory cells (3 x 105 cells per
well) for a CD4 T-cell (105 cells per
well) proliferation assay. Similar results
were obtained when the APCs were
titrated from 3 x 105 to 3 x 103 cells per
well (data not shown). (b) The expres-
sion of the costimulatory molecules B7-
2, B7-1 and HSA on APCs. Viable APCs
were stained with mAbs and second-
step reagents, and the expression of the
costimulatory molecules was deter-
mined by flow cytometry as described
in the legend to Fig. 3. Data shown are
the mean fluorescence of the samples
stained with a specific mAb; the back-
ground staining (fluorescence in the
presence of the second-step reagent
alone) was always below 20 and has
been subtracted. The data are represen-
tative of three independent experiments.
The apparently significant costimulatory
activity of B cells stimulated by mock-
transfected COS cells for 6 h in (a) was
not reproducible, and was probably due
to inadequate fixation of B cells.
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Fig. 5. CD40L-induced costimulatory activity is independent of
CD28. (a) FACS profiles of CD4 T cells isolated from either wild-
type (WT) or CD28-deficient (CD28-KO) mice. (b) Proliferation of
wild-type and CD28-KO T cells in response to B cells co-cultured
with either CD40L-transfected or control, untransfected fibroblasts.
B cells from CBA/CaJ mice were co-cultured for 16 h with the
fibroblasts, fixed with 0.1 % paraformaldehyde and used as APCs.
CD4 T cells (105 cells per well) were cultured with varying num-
bers of fixed B cells for 42 h, and their proliferation was measured
by the incorporation of [3H]TdR for the subsequent 6 h.
obtained one stable hybridoma that secreted a mono-
clonal antibody (TM-1) specific to a CD40L-induced
costimulatory activity. As shown in Figure 6a, TM-1 sig-
nificantly inhibited the costimulatory activity induced by
CD40L; the control hamster IgG monoclonal antibody
3H12 did not inhibit this activity.
The induction of TM-1-epitope expression corre-
lated with the induction of costimulatory activity. As
shown in Figure 6b, B cells cultured for 4 hours with
CD40L-transfected fibroblasts had potent costimulatory
activity for CD4 T-cell proliferation; this activity
increased until 16 hours of stimulation. Untransfected
fibroblasts did not induce costimulatory activity on B
cells. Correspondingly, B cells cultured with CD40L-
transfected fibroblasts expressed a significantly higher
level of TM-1 epitope at 4 hours than those cultured
with untransfected fibroblasts (Fig. 6c). The difference in
expression levels increased until 16 hours of culture.
However, these two populations of B cells expressed equal
levels of B7-2 at 4 hours and 8 hours of culture, although
a significant induction of B7-2 was observed at 16 hours
of stimulation. These results reaffirm the lack of correla-
tion between the induction of B7-2 and the existence of
costimulatory activity.
The TM-1 monoclonal antibody bound a single mole-
cule of- 85 kDa (Fig. 7a). Flow cytometry analysis indi-
cated that TM-1 does not bind B7-1, B7-2 or ICAM-1
(Fig. 7b). The molecular wight of molecule that TM-1
recognizes also precludes the possibility that TM-1 binds
other cell-surface molecules that are implicated in T cell
costimulation, such as ICAM-2, ICAM-3, integrins,
CD5 or 4-1BB ligand.
Discussion
Numerous studies have demonstrated that the interaction
between CD40 and CD40L is critical for immunological
help from T cells to B cells [23-29]. The role of this
interaction in T-cell activation is less clear. Although pre-
vious studies [19,23,30] indicate that the CD40L-CD40
interaction plays a critical role in the T-cell-mediated
induction of costimulatory activity on APCs, these exper-
iments have two major caveats. Firstly, the conclusion is
based on antibody-inhibition data, which could be due to
negative signaling rather than blocking. Secondly, and
more importantly, the expression of costimulatory activity
and costimulatory molecules was measured 24-48 hours
after TCR engagement. Costimulatory activity is
required within 6 hours of TCR engagement in order to
prevent clonal anergy of T cells [31,32]; it is therefore
questionable whether the expression of costimulatory
molecules measured in these previous studies is relevant.
In this study, we have used mice with targeted mutations
in the genes encoding CD40L or CD28 to test the role of
this interaction in T-cell mediated induction of costimula-
tory activity on B cells. We show that there is a significant
induction of costimulatory activity within 2 hours of
TCR engagement, and that T cells from wild-type mice
induce a significantly more rapid and more potent
costimulatory activity on APCs. Using COS cells trans-
fected with the CD40L gene, we demonstrate that the
induction of costimulatory activity by CD40L can be very
rapid, and occurs within 3 hours of CD40 engagement.
These results demonstrate unequivocally that CD40L is
necessary and sufficient for optimal induction by T cells
of costimulatory activity on the APCs. The rapid kinetics
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Fig. 6. The novel mAb TM-1 binds to a CD40L-induced costimulatory molecule. (a) TM-1 inhibits CD40L-induced costimulatory activ-
ity. B cells were stimulated by CD40L for 4 h, fixed with 0.1 % paraformaldehyde and then used as APCs (105 cells per well). CD4 T
cells isolated from C57BL/6j mice (105 cells per well) were stimulated by a 1:40 dilution of tissue culture supernatant from the anti-CD3
hybridoma 2C11. Different dilutions of supernatants from either the TM-1 hybridoma or the hamster IgG-producing hybridoma 3H12
were added at the beginning of culture. (b) Kinetics of induction of costimulatory activity on B cells by either CD40L-transfected or
untransfected fibroblasts, as measured by their ability to promote anti-CD3-induced proliferation of CD4 T cells, as in (a), except that
the B cells were stimulated for periods given. (c) Expression of TM-1 or B7-2 epitopes on the B cells stimulated by untransfected (dotted
lines) or CD40L-transfected fibroblasts, as assayed by flow cytometry. Aliquots of the same cells were used in (b,c).
of this induction suggest that CD40L-mediated induction is likely that a cytokine(s) can also up-regulate B7-2 on
of costimulatory activity may be involved in preventing APCs, as has been demonstrated by Hathcock et al. [36].
inactivation ofT cells following TCR engagement. It is possible that in the transgenic model used by Foy et
al. [22], the particular CD4 T cells may lack the ability to
A critical issue is the identity of the costimulatory mole- make this cytokine(s).
cules that are rapidly induced by CD40L-CD40 interac-
tion. Although Foy et al. [22] suggested that CD40L is
critical for B7-2 induction, we have found that the T-
cell-mediated induction of B7-2 is unaffected by targeted
mutation of the CD40L gene. Because the induction of
The simplest hypothesis to explain our observations -
that T cells from CD40L-deficient mice and wild-type
littermates induce equal levels of B7-2 but different levels
of costimulatory activity on APCs - is that CD40L can
B7-2 by T cells is contact-independent in our model, it induce other costimulatory molecules. In order to test
Fig. 7. Characterization of the CD40L-
induced costimulatory molecule recog-
nized by TM-1. (a) B cells stimulated by
CD40L for 16 h were cell-surface-
labeled with 1251, and lysed as described
[42]. Immunoprecipitation was carried
out using either a control mAb (hamster
anti-murine B7-1, which does not pre-
cipitate any molecules because B7-1 is
not expressed at this time point), or
TM-1. The precipitates were analyzed
using a 4-20 % gradient polyacrylamide
gel under reducing (R) or nonreducing
(N) conditions. The gel was autoradi-
ographed on a phosphoimager, and the
image obtained was processed and
developed using the Photoshop program
(Adobe). (b) TM-1 does not bind to
B7-1, B7-2 or ICAM-1, as determined
by flow cytometry. CHO cells trans-
fected with the B7-1 (top) or B7-2 (mid-
dle) gene, or COS cells transiently
transfected with the ICAM-1 gene (bot-
tom) were stained with either specific
mAbs or second-step reagents alone.
The binding of these mAbs was deter-
mined by the cell-surface fluorescence
of the second-step reagents. Data shown
are histograms of the FACS profiles.
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this directly, we analyzed the CD40L-mediated induction
of costimulatory activity and that of known costimula-
tory molecules. Our results show that the induction of
costimulatory activity precedes that of B7-1 and B7-2 -
the induction of the costimulatory activity could be
detected within 3 hours of CD40L-engagement, but no
induction of B7-2 could be detected before 12 hours of
culture. Such a disparity was not due to a lower sensitiv-
ity in the detection of B7-2 by FACS, because B7-2
could be detected on unstimulated spleen B cells (which
have no detectable costimulatory activity in our assay).
Using T cells from CD28-deficient mice, we also show
that the CD40L-induced costimulatory molecules are
independent of CD28, thereby precluding the possibility
that another unidentified B7 family member, such as
B7-3 [37], could be involved.
CD40L therefore induces a costimulatory molecule(s)
that is distinct from B7-1, B7-2 and HSA. We have pro-
duced a novel monoclonal antibody which binds an
85 kDa molecule that is involved in CD40L-induced
costimulatory activity. Immunochemical studies and
flow-cytometry analysis revealed that the monoclonal
antibody does not bind to B7-1, B7-2, HSA, ICAM-1,
ICAM-2, ICAM-3, CD40, CD40L or 4-1BB ligand.
That CD40L-induced B cells can costimulate CD28-
deficient T cells indicates that this novel costimulatory
activity functions in a CD28-independent fashion. Our
study may therefore explain the relatively mild immuno-
deficiency of the CD28-deficient mice. Although it has
been suggested that immune responses in the CD28-
deficient mice may represent costimulation-independent
T-cell responses [35], our study suggests that an alterna-
tive costimulatory pathway plays a major role in T-cell
responses in vivo.
Conclusions
This study demonstrates unequivocally a role for the
CD40L-CD40 interaction in T-cell-mediated induc-
tion of costimulatory activity on B cells. Furthermore,
novel costimulatory molecules are likely to be involved
in this process. We conclude that the CD40-CD40L
interaction plays a central role in the reciprocal interac-
tions between T and B cells, which result in their
mutual activation (see Fig. 8). Certain viral infections
[33] and certain immunoglobulin-antigen interactions
[17] have been shown directly to induce B7-2 on B
cells; under these conditions, the reciprocal conversa-
tion between T and B cells may therefore occur in the
absence of CD40L [5].
Fig. 8. Reciprocal communication between T and B cells. (1) B
cells capture antigens using a cell-surface immunoglobulin; this
antigen is then processed and presented to the cell surface as the
MHC-peptide complex. (2) T cells specific for this MHC-peptide
complex interact with the B cells. This interaction leads to
expression of the CD40L on the T cells. (3) interaction of CD40L
with CD40 leads to induction of costimulatory molecules. (4) T
cells interact with B cells that express both the MHC-peptide
complex and the costimulatory molecule; this interaction leads
to activation and clonal expansion of the T cells. (5) Similarly, B
cells whose immunoglobulin receptor has been engaged by anti-
gen can interact with the CD40L on T cells. This interaction
leads to activation and clonal expansion of the B cells.
Materials and methods
Experimental animals
The generation and breeding of the CD40L-deficient mice and
their wild-type littermates have been fully described [29]. Mice
with a targeted mutation of the CD28 gene, as described previ-
ously [38], have been back-crossed to C57BL/6j mice for six
generations and were kindly provided by Tak Mak (University
of Toronto, Ontario, Canada). Age-matched mice,
6-20 weeks old, were used for this study. C57BL/6.CD28 - /-,
C57BL/6j and CBA/CaJ mice aackson Laboratories, Bar
Harbor, Maine) were used as the source of CD4 T cells.
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T-cell proliferation assay
CD4 T cells were purified from mouse spleens as described [39].
Purified CD4 T cells (105 cells per well) were incubated with
fixed accessory cells and anti-CD3 monoclonal antibody (mAb)
2C11-145 [40] hybridoma supernatants at 1:40 dilution for 66 h.
T-cell proliferation was measured by pulsing the culture with
[3 H]TdR (1 pCi per well) for an additional 6 h. Data shown are
means of duplicates with variations of less than 15 % of the means.
Induction of costimulatory activity by anti-CD3-triggered
T cells
The basic protocol for the induction of costimulatory activity on
APCs by anti-CD3-triggered T cells has been fully described
[33]. To determine whether the defects in induction of costimu-
latory activity were due to T cells or APCs, T cells purified from
either CD40L-deficient mice or their wild-type littermates were
mixed with T-depleted spleen cells from either strain of mice and
stimulated with anti-CD3 mAb for 16 h, the T-depleted APCs
were isolated, and their fixation-resistant costimulatory activity
determined. To test the requirement for the cognate interaction
between T cells and APCs, the T-cell-depleted spleen cells were
separated from total spleen cells by a 0.2 lpm polycarbonate
membrane, and anti-CD3 mAb added at 1:40 dilution. After 16
h of culture, APCs from both chambers were isolated, fixed
with 0.1 % paraformaldehyde and their costimulatory activity
determined by the T-cell proliferation assay.
Induction of costimulatory activity by CD40L-transfected
fibroblasts
COS cells were transfected with the CD40L gene by the
DEAE-Dextran method [15] and used 72 h after transfection.
NIH 3T3 cell line p-2 were transfected with CD40L by lipo-
fection. After selection with neomycin, cells that were stably
expressing CD40L were obtained by three consecutive FACS
sorts using the anti-CD40L mAb MR1 [27]. B cells were puri-
fied from CBA/CaJ mice using magnetic beads (Dynal) as has
been described [34]. Using this method, the purity of B cells is
more than 99 %, and contamination of macrophages and den-
dritic cells is not detectable [34]. B cells (5 x 106 ml-1) and
confluent CD40L-transfectants were co-cultured for a given
period of time. The viable APCs were used for analysis of
induction of costimulatory molecules by flow cytometry or
were fixed with 0.1 % paraformaldehyde and assayed for their
fixation-resistant costimulatory activity.
Flow cytometric analysis of the cell-surface expression of
the costimulatory molecules B7-1, B7-2, ICAM- 1 and HSA
Spleen APCs (106 cells per well), activated by T cells, were incu-
bated with anti-B7-1 mAb 3A12 [39], anti-B7-2 mAb GL-I
[41] or anti-HSA mAb 20C9 [15] (hybridoma supernatants used
at saturating doses). The binding of GL-1 was detected with
mouse anti-rat IgG (Accurate, New York, USA); the binding
of 3A12 and 20C9 was detected with the FTC-labelled goat
anti-hamster IgG (Caltag, Mountainview, California, USA).
CHO cells, stably transfected with the B7-1 or B7-2 gene as
described [39,42], or COS cells transiently transfected with the
ICAM-1 gene [43], were stained with the novel mAb TM-1.
Antibodies against B7-1 (3A12), B7-2 (GL-1) and ICAM-1
(YN1/1.7.4; [44]) were used as positive controls.
Production of monoclonal antibodies against
CD40L-induced costimulatory molecules
Armenian hamsters were immunized intraperitoneally with 107 B
cells which had been stimulated by CD40L for 5 h. Two weeks
later, the hamsters were boosted with the CD40L-activated B
cells and, three days after boost, spleen cells from the hamsters
were fused with myeloma Ag8.653. The hybridoma super-
natants were screened for the inhibition of CD4 T-cell prolif-
eration using fixed, CD40L-activated B cells as costimulatory
cells. Positive clones were screened for their binding to resting
versus CD40L-activated B cells. Clones that preferentially
bound activated B cells were cloned a further three times. The
mAb derived from stable clone TM-1 was used for this study.
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